Document is current
Any future updates will be listed below
-
Authors
Korol, Sandra
White, Michel
O’Meara, Eileen
Rouleau, Jean-Lucien
White-Guay, Brian
Dorais, Marc
Ahmed, Ali
de Denus, Simon
Perreault, Sylvie
-
Funding
Funding for this research was provided by:
R?seau Qu?b?cois de Recherche sur les M?dicaments
- License Information
-
More Information
Article History
Received: 9 May 2018
Accepted: 18 December 2018
First Online: 13 February 2019
Compliance with ethical standards
:
: Sandra Korol: Sandra Korol received funding from Fonds de recherche du Québec – Santé (FRQS). Michel White: Dr. White received research grants from Bayer, Jenssen, Novartis, and Pfizer. He was a consultant for Jenssen USA and Arca Biopharma USA, and was a conference speaker for Bayer, Novartis, Pfizer, BMS, Servier, and BI. Simon de Denus: Dr. de Denus has received research grants or been a co-investigator on grants supported by AstraZeneca, Novartis, Roche and Pfizer. He has received speaker fees from Pfizer and consulting fees from Servier and Novartis. All other authors declare that they have no conflicts of interest.
